Advanced Glycation Endproducts and Alendronate Differentially Inhibit Early and Late Osteoclastogenesis <i>in vitro</i>
Advanced Glycation Endproducts (AGEs) are greatly elevated in bone extracellular matrix of patients with Diabetes mellitus, and this has been associated with the increased incidence of fractures observed in these patients. AGEs affect the homeostasis of bone cells such as osteoblasts and osteoclasts...
Guardado en:
| Autores principales: | Gangoiti, María Virginia, Arnol, Verónica, Cortizo, Ana María, McCarthy, Antonio Desmond |
|---|---|
| Formato: | Articulo |
| Lenguaje: | Inglés |
| Publicado: |
2013
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/98429 https://ri.conicet.gov.ar/11336/23956 |
| Aporte de: |
Ejemplares similares
-
Advanced glycation endproduct-specific receptors in rat and mouse osteoblast-like cells: regulation with stages of differentiation
por: McCarthy, Antonio Desmond, et al.
Publicado: (1999) -
Advanced glycation endproducts interfere with integrin-mediated osteoblastic attachment to a type-I collagen matrix
por: McCarthy, Antonio Desmond, et al.
Publicado: (2004) -
Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development
por: McCarthy, Antonio Desmond, et al.
Publicado: (2001) -
Opposing effects of bisphosphonates and advanced glycation end-products on
osteoblastic cells
por: Gangoiti, María Virginia, et al.
Publicado: (2008) -
AGE-R3/galectin-3 expression in osteoblast-like cells: Regulation by AGEs
por: Mercer, Natalia, et al.
Publicado: (2004)